Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia

Diabetes
M FedericiG Sesti

Abstract

The insulin receptor (IR) shares structural and functional homology with the IGF-I receptor (IGF-IR). Hybrid receptors composed of an IR alphabeta-heterodimer and an IGF-IR alphabeta-heterodimer are formed in tissues expressing both molecules. Hybrids behave as IGF-IR rather than IR with respect to ligand binding affinity, receptor autophosphorylation, and hormone internalization and degradation. Factors regulating hybrid formation in vivo are unknown. We recently reported that in skeletal muscle of NIDDM patients, expression of hybrids is increased and correlated with a decrease in IR number and an increase in fasting insulin levels. However, it is not clear whether increased expression of hybrid receptors is a primary defect specifically associated with NIDDM or a secondary event caused by hyperinsulinemia. To address this issue, we used a quantitative microwell-based immunoassay to measure hybrid receptor abundance in skeletal muscle of 11 normal subjects and 12 patients with insulinoma, a state of primary nongenetically determined hyperinsulinemia. Total insulin binding was lower in insulinoma patients than in normal subjects (0.70 +/- 0.18 vs. 4.59 +/- 0.77; P < 0.0001). Total IGF-I binding did not differ between the two g...Continue Reading

Citations

Jan 23, 2013·Pflügers Archiv : European journal of physiology·V Kate GatenbyMark Kearney
Jan 27, 2000·Cytokine & Growth Factor Reviews·B R LackeyD M Henricks
Apr 2, 1999·Acta Paediatrica. Supplement·A J D'Ercole
May 5, 2012·Diabetes·Swapnil N RajpathakHoward D Strickler
Apr 1, 2008·International Journal of Diabetes in Developing Countries·Srinivas MarthaKrishna Devarakonda
Jan 2, 2014·Trends in Endocrinology and Metabolism : TEM·Rodrigo TroncosoSergio Lavandero
Dec 13, 2006·Best Practice & Research. Clinical Endocrinology & Metabolism·Giorgio Sesti
Sep 13, 2015·Molecular and Cellular Endocrinology·Revathy CarnagarinCrispin R Dass
Aug 15, 2014·Acta Diabetologica·Andrea GiustinaG Mazziotti
Jan 16, 2009·Diabetes/metabolism Research and Reviews·Swapnil N RajpathakHoward D Strickler
Jan 26, 2002·British Medical Bulletin·C D Byrne
May 13, 2004·Critical Care Nursing Quarterly·Prakash L Mokshagundam
Aug 24, 1999·Endocrine Reviews·L PoretskyL C Giudice
Nov 7, 2019·Current Pharmaceutical Design·Milan ObradovicEsma R Isenovic
Dec 21, 2006·BJU International·Miles A GoldstrawRoger S Kirby
Jan 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Yevgeniya S KushchayevaRebecca J Brown
Oct 9, 2018·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Romana S MughalMark T Kearney
Jan 16, 2004·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C PenderJ F Youngren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.